Neutron Therapeutics’ nuBeam® Uses Cosylab's OncologyOne Software to Reach Critical BNCT Milestones

Neutron Therapeutics, Inc. (Neutron Therapeutics) was founded in 2015 and is the manufacturer of nuBeam®, a revolutionary, state-of-the-art Boron Neutron Capture Therapy (BNCT) device for the hospital setting. This device will help transform groundbreaking medical research into a widely available, first-line system for highly targeted radiation treatment of cancer patients. The company believes that BNCT will soon be a powerful and widely available tool for radiation oncologists, expanding the arsenal of available treatments for patients who have run out of options.

Designing, Operating and Financing a BNCT Center

The reborn boron neutron capture therapy (BNCT) is one of the exciting radiation therapy modalities entering the clinical mainstream worldwide, propelled by the success of accelerator-based technology. The latter allows for compact installations in existing or new hospital spaces with small footprints. 

The Second RAPTOR School Success Shows the Way Forward for Advanced Adaptive Particle Therapy

In September 2022, the 2nd RAPTOR School "Loop Requirements", hosted by Cosylab in Ljubljana, concluded successfully with the participants' wholehearted acclaim. Researchers shared their latest findings on advanced adaptive particle therapy (PT) for cancer treatment and attended technical and scientific classes, lectures and meetings. 

A Revolutionary Upright Radiation Therapy System Developed with OncologyOne

Leo Cancer Care Ltd. (Leo Cancer Care) is an innovative British and US medical company designing and developing cancer treatment systems that simplify radiation therapy (RT) and make it more human. Leo Cancer Care started with the logical question: why rotate the radiation therapy device if we can rotate the upright patient and put the therapy chair in a smaller treatment room, making RT more accessible than ever before?

Quality Assurance for AI Software and Machine Learning

The time when artificial intelligence (AI) was limited to labs and research groups is long gone. Its widespread presence in the internet-related industry (search engines, social networks, e-commerce) is now obvious to practically everyone, and we can no longer imagine the IT world without it. Today, the application of AI has spread to all kinds of industries, including those where reliability and safety are critical, and where strict regulations apply. And since quality assurance (QA) is an essential contributor to safety, it has become necessary to develop QA and regulatory frameworks for higher risk AI applications.

Treatment room of the future

One of the most essential elements of the radiation therapy facility is the treatment room. The latter is not only the shielded vault where the cancer patient receives their planned radiation dose but also the place which connects all the in-room imaging, positioning and treatment functionalities of radiation therapy.

The Final Frontier of Radiation Therapy

With advances in radiation therapy, cancer treatment has come a long way in the last twenty years. Therapy with high-energy photons from medical linacs has become the mainstay of oncology and saves millions of lives each year. At the same time, a multitude of advanced radiation therapy modalities has reached maturity, such as particle, boron neutron capture and heavy-ion therapy. The clinical and manufacturer communities are now concentrating on optimising, leveraging and consolidating the performance and capabilities of specific subsystems and elements of radiation therapy devices and facilities worldwide.

Boron Neutron Capture Therapy (Part II) – Industrial Aspects

Irradiating cancer cells from "the inside out" without affecting healthy tissue has been a dream of medical physicists and oncologists for almost a century.
Cosylab_Boron Neutron Capture Therapy_BNCT

Boron Neutron Capture Therapy (Part I) – Current and Future Clinical Aspects

Boron neutron capture therapy (BNCT) is not yet a "household name" at your nearest oncology ward, but it may soon become one. It is a two-step treatment combining the infusion of a drug containing boron-10 and irradiation with low-energy neutrons. Neither the drug nor the neutron beam are Independently toxic and affect healthy tissue minimally.
Cosylab_Boron Neutron Capture Therapy_featured

Boron Neutron Capture Therapy: When Drugs and Neutrons Combine

A next-generation cancer treatment is now heading to your neighbourhood clinic, and it's called Boron Neutron Capture Therapy (BNCT). It has the potential to deliver highly effective and very cell-selective radiation therapy with a truly low impact on the patient's quality of life, possibly less than all other radiation, chemotherapy or biological therapy modalities in current use.